Literature DB >> 8896458

Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.

S R McKercher1, B E Torbett, K L Anderson, G W Henkel, D J Vestal, H Baribault, M Klemsz, A J Feeney, G E Wu, C J Paige, R A Maki.   

Abstract

PU.1 is a member of the ets family of transcription factors and is expressed exclusively in cells of the hematopoietic lineage. Mice homozygous for a disruption in the PU.1 DNA binding domain are born alive but die of severe septicemia within 48 h. The analysis of these neonates revealed a lack of mature macrophages, neutrophils, B cells and T cells, although erythrocytes and megakaryocytes were present. The absence of lymphoid commitment and development in null mice was not absolute, since mice maintained on antibiotics began to develop normal appearing T cells 3-5 days after birth. In contrast, mature B cells remained undetectable in these older mice. Within the myeloid lineage, despite a lack of macrophages in the older antibiotic-treated animals, a few cells with the characteristics of neutrophils began to appear by day 3. While the PU.1 protein appears not to be essential for myeloid and lymphoid lineage commitment, it is absolutely required for the normal differentiation of B cells and macrophages.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896458      PMCID: PMC452309     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  75 in total

Review 1.  Positive selection of thymocytes.

Authors:  S C Jameson; K A Hogquist; M J Bevan
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

Review 2.  Hematopoietic lineage commitment: role of transcription factors.

Authors:  J H Kehrl
Journal:  Stem Cells       Date:  1995-05       Impact factor: 6.277

3.  Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation.

Authors:  J M Pongubala; C Van Beveren; S Nagulapalli; M J Klemsz; S R McKercher; R A Maki; M L Atchison
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

4.  CD18 (beta 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity.

Authors:  A G Rosmarin; D Caprio; R Levy; C Simkevich
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

Review 5.  Transcription factors and hematopoietic development.

Authors:  S H Orkin
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

6.  The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter.

Authors:  H L Pahl; R J Scheibe; D E Zhang; H M Chen; D L Galson; R A Maki; D G Tenen
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

7.  Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype.

Authors:  D W Threadgill; A A Dlugosz; L A Hansen; T Tennenbaum; U Lichti; D Yee; C LaMantia; T Mourton; K Herrup; R C Harris
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

8.  Strain-dependent epithelial defects in mice lacking the EGF receptor.

Authors:  M Sibilia; E F Wagner
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

9.  T-cell lineage commitment and cytokine responses of thymic progenitors.

Authors:  T A Moore; A Zlotnik
Journal:  Blood       Date:  1995-09-01       Impact factor: 22.113

10.  Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cells.

Authors:  E A Faust; D C Saffran; D Toksoz; D A Williams; O N Witte
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  321 in total

1.  MafB is an inducer of monocytic differentiation.

Authors:  L M Kelly; U Englmeier; I Lafon; M H Sieweke; T Graf
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

2.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Mutation analysis of the Pip interaction domain reveals critical residues for protein-protein interactions.

Authors:  M A Ortiz; J Light; R A Maki; N Assa-Munt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

4.  Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.

Authors:  Jynho Kim; Ricardo A Feldman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

5.  The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.

Authors:  E Torlakovic; A Tierens; H D Dang; J Delabie
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

6.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

7.  Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb.

Authors:  M Britos-Bray; A D Friedman
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

8.  The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation.

Authors:  Mark W Feinberg; Akm Khyrul Wara; Zhuoxiao Cao; Maria A Lebedeva; Frank Rosenbauer; Hiromi Iwasaki; Hideyo Hirai; Jonathan P Katz; Richard L Haspel; Susan Gray; Koichi Akashi; Julie Segre; Klaus H Kaestner; Daniel G Tenen; Mukesh K Jain
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

9.  PU.1-silenced dendritic cells prolong allograft survival in rats receiving intestinal transplantation.

Authors:  Xing-Wei Xu; Bo-Wen Ding; Chuan-Rong Zhu; Wu Ji; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 10.  Microglia in Alzheimer's disease.

Authors:  Heela Sarlus; Michael T Heneka
Journal:  J Clin Invest       Date:  2017-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.